Drug
Selegiline clinical trials
Also written EMSAM and Zelapar.
- studies test it
- 26
- open now
- 0
- in phase 3
- 2
- first study started
- 1994
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
23 studies that test it; most in 2007 (8)
| Year | Studies |
|---|---|
| 1994 | 2 |
| 1995 | 1 |
| 2001 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 8 |
| 2012 | 2 |
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 3
- Phase 2
- 10
- Phase 3
- 2
- Phase 4
- 7
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 24
National Institute on Drug Abuse (NIDA) (7) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Somerset Pharmaceuticals (2) · Baylor College of Medicine (1) · Ludwig-Maximilians - University of Munich (1) · Second Affiliated Hospital of Soochow University (1) · Stanford University (1) · Mood and Anxiety Research, Inc (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Selegiline is read from its arms, and is right about nine times in ten.
Testing it · 26
- Selegiline to Zelapar Switch Study in Parkinson Disease PatientsCompletedPhase 4Baylor College of MedicineNCT00640159Written as Zelapar
- Pharmacokinetic Profile of Betahistine With and Without Selegiline in Healthy VolunteersCompletedPhase 1Ludwig-Maximilians - University of MunichNCT05938517Written as Selegiline-hydrochloride
- Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV PatientsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00013585Written as Selegiline hydrochloride
- Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's DiseaseCompletedPhase 4Second Affiliated Hospital of Soochow UniversityNCT04870372Written as Selegiline
- Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate AdenocarcinomaStatus unknownPhase 2László MangelNCT04586543Written as Selegiline
- Selegiline and Reward ProcessingStatus unknownNot applicableUniversity of OxfordNCT04130087Written as Selegiline Hydrochloride 10 MG
- Sagene 2014 - Parkinson's Disease and Erectile DysfunctionStatus unknownPhase 4University of South FloridaNCT02225548Written as Selegiline
- Selegiline for Smoking Cessation - 1CompletedPhase 2National Institute on Drug Abuse (NIDA)NCT00439413Written as Selegiline Transdermal Patch
- Selegiline in Outpatient Treatment for Cocaine Dependence - 1CompletedPhase 2National Institute on Drug Abuse (NIDA)NCT00000336Written as Selegiline
- Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1CompletedPhase 3National Institute on Drug Abuse (NIDA)NCT00032929Written as Selegiline
- Pharmacological Modulation of Cocaine Effects - 1CompletedPhase 2National Institute on Drug Abuse (NIDA)NCT00000201Written as Selegiline
- Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1CompletedPhase 2National Institute on Drug Abuse (NIDA)NCT00218517Written as Selegiline hydrochloride
- Infusion Laboratory: Protocol 1 - Selegeline - 2CompletedPhase 1National Institute on Drug Abuse (NIDA)NCT00000337Written as Selegiline
- Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Status unknownPhase 1National Institute on Drug Abuse (NIDA)NCT00033072Written as Selegiline
- Selegiline Patch for Treatment of Nicotine DependenceCompletedPhase 2Stanford UniversityNCT01330030Written as Selegiline
- Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality DisorderCompletedPhase 3Mood and Anxiety Research, IncNCT01912391Written as Selegiline
- Selegiline in Treatment of Cocaine Dependence - 2CompletedPhase 2University of PennsylvaniaNCT00000188Written as Selegiline
- Usefulness of Selegiline as an Aid to Quit Smoking - 1CompletedPhase 2Yale UniversityNCT00129311Written as Selegiline
- A Study of Decreased Mental Function Associated With HIVCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00027040Written as Selegiline hydrochloride
- Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine AgonistsCompletedPhase 4Parkinson's Disease and Movement Disorder Center of Boca RatonNCT00443872Written as orally disintegrating selegiline (Zelapar)
See all 26 studies that test Selegiline →
As the comparator · 1 — what is tested is compared with Selegiline
Codes
What other systems call Selegiline · ClinicalTrials.gg INT008186
- MeSH (NLM) D012642SelegilineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 2K1V7GP655SELEGILINEConfirmed FDA, NLM, Wikidata
- RxNorm 9639Confirmed FDA, Wikidata
- Wikidata Q47495783(−)-selegilineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61938SelegilineConfirmed FDA, Wikidata
- DrugBank DB01037One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D012642 | Selegiline | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 2K1V7GP655 | SELEGILINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 9639 | — | Confirmed FDA, Wikidata |
| Wikidata | Q47495783 | (−)-selegiline | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61938 | Selegiline | Confirmed FDA, Wikidata |
| DrugBank | DB01037 | — | One source Wikidata |
Also registered as selegiline hydrochloride (UNII 6W731X367Q · RxNorm 203137).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.